Neuroscience News and Research

RSS

Multiple sclerosis drug natalizumab may reduce immunity

A drug used to treat multiple sclerosis might make some patients vulnerable to brain infection by reducing the number of immune cells there, researchers at UT Southwestern Medical Center have found.

16 Dec 2008

Overactive brain enzyme may play role in preventing weight gain and obesity

Researchers at Albert Einstein College of Medicine of Yeshiva University have found that overactivity of a brain enzyme may play a role in preventing weight gain and obesity.

14 Dec 2008

Amputees can experience prosthetic hand as their own

Scientists at Karolinska Institutet and Lund University in Sweden have succeeded in inducing people with an amputated arm to experience a prosthetic rubber hand as belonging to their own body.

12 Dec 2008

Sugar is addictive

A Princeton University scientist will present new evidence today demonstrating that sugar can be an addictive substance, wielding its power over the brains of lab animals in a manner similar to many drugs of abuse.

10 Dec 2008

New spinal deformity classification system

A University of Cincinnati (UC) neurosurgeon who has spent his career helping people with severe spine problems stand up straight has spearheaded the creation of a new spinal deformity classification system.

10 Dec 2008

New research points to possible treatment for Lou Gehrig's disease

There are many ways to die, but amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease must be one of the worst.

10 Dec 2008

Researchers explore neural mechanisms behind responsibility and punishment

A new study reveals that humans use different neural mechanisms for determining criminal responsibility and assigning an appropriate punishment.

10 Dec 2008

Cellular 'brakes' may slow memory process in aging brains

University of Florida researchers may have discovered why some brain cells necessary for healthy memory can survive old age or disease, while similar cells hardly a hairsbreadth away die.

10 Dec 2008

Amblyopia treatment times could be drastically reduced

Amblyopia is thought to affect up to 2.5 per cent of people and accounts for around 90 per cent of all children's eye appointments in the UK. Occlusion therapy - patching the normal eye for lengthy periods to 'train' the affected eye - is the main treatment for amblyopia.

10 Dec 2008

AstraZeneca and Targacept announce results from trial of AZD3480 for cognitive dysfunction in schizophrenia

AstraZeneca and Targacept, Inc. havey announced top-line results from a Phase IIb clinical trial of AZD3480 (TC-1734) conducted by AstraZeneca in cognitive dysfunction in schizophrenia (CDS), known as the HALO trial.

10 Dec 2008

Neuronetrix announces preliminary study results for COGNISION System to diagnose Alzheimer's

Last week, at the Society for Neuroscience Conference in Washington DC, Neuronetrix announced preliminary results from a clinical study of their COGNISION System to diagnose Alzheimer's disease.

8 Dec 2008

Changes in medical terminology confuses patients

The label used to identify a disease - whether it is common language or medical terminology - can influence how serious people think the condition is, according to new research from McMaster University, the second part of a larger study on how people understand and interpret disease.

8 Dec 2008

Novel approach to disseminate trial results to study volunteers

While an estimated 2.3 million people in the U.S. take part in clinical trials every year, there currently exists no formal requirement to inform them of study results; an oversight that leaves participants confused, frustrated, and, in some cases, lacking information that may be important to their health.

8 Dec 2008

Study links cone death in retinitis pigmentosa to metabolic problem

Rods and cones coexist peacefully in healthy retinas. Both types of cells occupy the same layer of tissue and send signals when they detect light, which is the first step in vision.

8 Dec 2008

Hemichannels - new target to treat epileptic seizures following brain trauma or stroke

New therapies for some forms of epilepsy may soon be possible, thanks to a discovery made by a team of University of British Columbia and Vancouver Coastal Health Research Institute neuroscience researchers.

8 Dec 2008

Potential new target for drugs to prevent HIV-associated dementia

A new study led by researchers at Albert Einstein College of Medicine of Yeshiva University has clarified how two major variants of HIV differ in their ability to cause neurologic complications.

3 Dec 2008

Discovery of gene variants that impact the placebo effect

It is a well-known fact in drug trials that individuals can respond just as well to placebos, sugar pills, as to the active drug.

3 Dec 2008

Brains of low-income children function differently from brains of high-income kids

University of California, Berkeley, researchers have shown for the first time that the brains of low-income children function differently from the brains of high-income kids.

3 Dec 2008

Breakthrough in strategy used to develop new pharmacological treatments for schizophrenia

In one of the first instances of targeted drug design in psychiatric treatment, University of Pittsburgh researchers have found an experimental agent that shows promise in addressing working memory impairments that occur in schizophrenia.

1 Dec 2008

High levels of prenatal smoking exposure affects sleep in early babies

A study in the Dec. 1 issue of the journal Sleep is the first to show that high levels of prenatal smoking exposure strongly modify sleep patterns in preterm neonates, which places infants at a higher risk for developmental difficulties that could persist throughout early and middle childhood.

1 Dec 2008